Enlaza Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
66
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$15M
- Investors
-
13
Enlaza Therapeutics General Information
Description
Developer of covalent protein therapeutics intended to deliver targeted treatments for oncology and autoimmune diseases. The company offers a novel synthetic biology platform that uses covalent bonds to lock onto a target protein that provides sustained occupancy and prolonged biologic effect with minimal systemic exposure, enabling healthcare professionals to treat various diseases.
Contact Information
Website
www.enlazatx.comCorporate Office
- 11099 North Torrey Pines Road
- Suite 280, La Jolla
- San Diego, CA 92037
- United States
Corporate Office
- 11099 North Torrey Pines Road
- Suite 280, La Jolla
- San Diego, CA 92037
- United States
Enlaza Therapeutics Timeline
Enlaza Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series A1) | 10-Sep-2025 | $15M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 30-Apr-2024 | Completed | Startup | |||
| 1. Seed Round | 15-Dec-2022 | $61M | $61M | Completed | Startup |
Enlaza Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Enlaza Therapeutics Comparisons
Industry
Financing
Details
Enlaza Therapeutics Competitors (3)
One of Enlaza Therapeutics’s 3 competitors is Dunad Therapeutics, a Venture Capital-Backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dunad Therapeutics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Avilar Therapeutics | Venture Capital-Backed | Waltham, MA | ||||
| Matchpoint Therapeutics | Venture Capital-Backed | Cambridge, MA |
Enlaza Therapeutics Patents
Enlaza Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026107097-A1 | Self-immolative linkers and conjugates thereof | Pending | 13-Nov-2024 | ||
| AU-2023275779-A1 | Crosslinking multispecific antibodies | Pending | 27-May-2022 | ||
| EP-4532564-A1 | Crosslinking multispecific antibodies | Pending | 27-May-2022 | ||
| EP-4532564-A4 | Crosslinking multispecific antibodies | Pending | 27-May-2022 | ||
| US-20250353926-A1 | Crosslinking multispecific antibodies | Pending | 27-May-2022 | C07K16/30 |
Enlaza Therapeutics Signals
Enlaza Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Amgen Ventures | Corporate Venture Capital | Minority | ||
| Avalon Ventures | Venture Capital | Minority | ||
| Bregua Corporation | Venture Capital | Minority | ||
| JP Morgan Asset Management | Asset Manager | Minority |
Enlaza Therapeutics FAQs
-
When was Enlaza Therapeutics founded?
Enlaza Therapeutics was founded in 2020.
-
Where is Enlaza Therapeutics headquartered?
Enlaza Therapeutics is headquartered in San Diego, CA.
-
What is the size of Enlaza Therapeutics?
Enlaza Therapeutics has 66 total employees.
-
What industry is Enlaza Therapeutics in?
Enlaza Therapeutics’s primary industry is Drug Discovery.
-
Is Enlaza Therapeutics a private or public company?
Enlaza Therapeutics is a Private company.
-
What is the current valuation of Enlaza Therapeutics?
The current valuation of Enlaza Therapeutics is .
-
What is Enlaza Therapeutics’s current revenue?
The current revenue for Enlaza Therapeutics is .
-
How much funding has Enlaza Therapeutics raised over time?
Enlaza Therapeutics has raised $176M.
-
Who are Enlaza Therapeutics’s investors?
Alexandria Venture Investments, Amgen Ventures, Avalon Ventures, Bregua Corporation, and JP Morgan Asset Management are 5 of 13 investors who have invested in Enlaza Therapeutics.
-
Who are Enlaza Therapeutics’s competitors?
Dunad Therapeutics, Avilar Therapeutics, and Matchpoint Therapeutics are competitors of Enlaza Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process